Sales Dependence on Core Product Kaiteki Oligo (an oligosaccharide product)
First written in FY2016. 4 of 5 entries say "Mitigated", first in FY2017-Q1. Latest entry: FY2017.
The whole theme swung hardest in 2024: 13 of 48 companies on the "Worse" side.
23 other companies' latest entry also says "Mitigated".
- FY2017MitigatedAnnual report
「Meanwhile, with the launch of these new product lines, dependence on revenue from Kaiteki Oligo, which had reached 85.2% in the fiscal year ended February 2012, immediately before the company's May 2012 listing on the Sapporo Securities Exchange's Ambitious Market, improved to 34.1% in the fourth quarter.」
The expansion of new product lines reduced quarterly revenue dependence on Kaiteki Oligo to 34.1%. However, full-year dependence was disclosed at 40.6%, so metrics covering different periods are presented together. - FY2017-Q3MitigatedAnnual report
「Meanwhile, with the launch of these new product lines, dependence on revenue from Kaiteki Oligo, which had accounted for 85.2% in the fiscal year ended February 2012, immediately before the company's May 2012 listing on the Sapporo Securities Exchange's Ambitious Market, improved to 37.7% in the third quarter.」
The expansion of new product lines reduced dependence on revenue from Kaiteki Oligo to 37.7%, representing a further improvement from the level disclosed previously. - FY2017-Q2MitigatedAnnual report
「As a result, dependence on revenue from Kaiteki Oligo improved further during the second quarter, while sales of the product itself remained solid. On 15 July 2016, it achieved the highest sales in Japan in the retail oligosaccharide market.」
The company explains that the expansion of new products further reduced dependence on the core product for revenue. - FY2017-Q1MitigatedAnnual report
「As a result, we have been able to steadily increase revenue across all products without undue concentration in any one product.」
The company explains that revenue has grown across its products without concentration, indicating a move to reduce dependence on revenue from a specific core product. - FY2016First statedAnnual report
「Revenue from our core product, Kaiteki Oligo, accounted for 47.6% of our revenue in the fiscal year ended February 2016.」
Although this dependence has declined from 85.2% in the 11th fiscal year, the company discloses the risk of an unforeseen event affecting the procurement or sale of a particular product.